TP53 and colorectal cancer: Furthermore, MDM2 has been identified as a crucial biomarker in many malignancies e.g lung cancer, breast cancer, liver cancer, esophagogastric cancer and colorectal cancer as it plays an important role in the control of p53 and the onset of cancer (38).